Voorbeelden van het gebruik van Dosing should in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
An interruption of dosing should be considered.
Dosing should be modified based on Kyprolis toxicity.
In these patients dosing should be managed cautiously.
Dosing should commence at the adult starting dose. .
If this does not happen by day 50, dosing should be stopped.
As the dosing should fall within 1% of the set point value.
There is no evidence currently available to indicate that dosing should be adjusted in older people.
Dosing should be continued with a once-weekly injection of 160 mg.
In the management of blepharospasm, total dosing should not exceed 100 U every 12 weeks.
Further dosing should continue at the usual time.
In the management of blepharospasm total dosing should not exceed 100 U every 12 weeks.
Dosing should be delayed in the presence of elevated ciclosporin blood levels.
the lowest available strength, alternate day dosing should be considered.
Dosing should be titrated to attain trough concentrations of 5 to 15 ng/ml.
serum ferritin is≤2,000 µg/l, dosing should not exceed 10 mg/kg.
Therefore, dosing should be adjusted according to their renal and hepatic status.
Elderly patients There is no evidence currently available to indicate that dosing should be adjusted in elderly patients.
Dosing should be delayed in the presence of elevated ciclosporin blood levels.
Missed doses should not be replaced and the dosing should resume with the next scheduled daily dose see section 4.9.
Dosing should be based on body weight as shown in the table below.
Where peroxisome proliferation studies are conducted, they should be carried out in the rat and dosing should be a minimum of 14 days in duration.
This type of dosing should also result from few side effects for the user.
If a reslizumab infusion is missed on the planned date, dosing should resume as soon as possible on the indicated dose and regimen.
Dosing should be less than 5 ml twice daily for children weighing less that 40 kg.
Target whole blood trough concentration recommendations Dosing should primarily be based on clinical assessments of rejection and tolerability in each individual patient.
Dosing should be titrated as necessary to maintain the haemoglobin target.
severe non-haematological toxicity develops, dosing should be interrupted,
Dosing should be interrupted in patients with ALT
If this dose is well tolerated, dosing should be increased to 5 microgram iloprost
Dosing should be spread out throughout the day